PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+20.26%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.78B
AUM Growth
+$476M
(+21%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
4.26%
Top 10 Holdings %
Top 10 Hldgs %
41.05%
Holding
1,048
New
64
Increased
345
Reduced
583
Closed
56
Top Buys
| 1 |
NVIDIA
NVDA
|
+$15.2M |
| 2 |
Microsoft
MSFT
|
+$15.1M |
| 3 |
Apple
AAPL
|
+$11.5M |
| 4 |
Shopify
SHOP
|
+$10.5M |
| 5 |
Broadcom
AVGO
|
+$8.66M |
Top Sells
| 1 |
Salesforce
CRM
|
+$2.4M |
| 2 |
Arista Networks
ANET
|
+$1.92M |
| 3 |
Snowflake
SNOW
|
+$1.37M |
| 4 |
Insmed
INSM
|
+$1.26M |
| 5 |
Exxon Mobil
XOM
|
+$1.25M |
Sector Composition
| 1 | Technology | 46.81% |
| 2 | Communication Services | 11.24% |
| 3 | Consumer Discretionary | 11.17% |
| 4 | Healthcare | 8.44% |
| 5 | Financials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Cigna
CI
$80.6B
| $1.13M | 0.04% |
3,412
-333
| -9% | -$110K |
|
277
Krystal Biotech
KRYS
$4.09B
| $1.12M | 0.04% |
8,166
+2,203
| +37% | +$303K |
|
278
Revolution Medicines
RVMD
$7.65B
| $1.12M | 0.04% |
30,494
-5,015
| -14% | -$185K |
|
279
Elevance Health
ELV
$71B
| $1.12M | 0.04% |
2,884
-288
| -9% | -$112K |
|
280
KKR & Co
KKR
$122B
| $1.12M | 0.04% |
8,426
-979
| -10% | -$130K |
|
281
Live Nation Entertainment
LYV
$39.5B
| $1.12M | 0.04% |
7,374
-3,562
| -33% | -$539K |
|
282
CVS Health
CVS
$91B
| $1.11M | 0.04% |
16,155
-1,093
| -6% | -$75.4K |
|
283
CME Group
CME
$94.3B
| $1.11M | 0.04% |
4,033
-892
| -18% | -$246K |
|
284
Lockheed Martin
LMT
$107B
| $1.08M | 0.04% |
2,341
+220
| +10% | +$102K |
|
285
Waste Management
WM
$88.3B
| $1.07M | 0.04% |
4,671
+848
| +22% | +$194K |
|
|
SWTX
286
DELISTED
SpringWorks Therapeutics
SWTX
| $1.07M | 0.04% |
22,726
-508
| -2% | -$23.9K |
|
287
Howmet Aerospace
HWM
$72.2B
| $1.06M | 0.04% |
5,698
+1,339
| +31% | +$249K |
|
288
Akero Therapeutics
AKRO
$3.57B
| $1.06M | 0.04% |
19,805
+3,757
| +23% | +$200K |
|
289
Protagonist Therapeutics
PTGX
$3.63B
| $1.05M | 0.04% |
19,074
+7,515
| +65% | +$415K |
|
290
Okta
OKTA
$16.5B
| $1.04M | 0.04% |
10,451
+915
| +10% | +$91.5K |
|
291
Petrobras Class A
PBR.A
$73.4B
| $1.04M | 0.04% |
90,511
-4,642
| -5% | -$53.6K |
|
292
CMS Energy
CMS
$21.2B
| $1.04M | 0.04% |
15,037
+3,271
| +28% | +$227K |
|
293
Halliburton
HAL
$18.5B
| $1.04M | 0.04% |
51,045
+146
| +0.3% | +$2.98K |
|
294
FirstEnergy
FE
$25B
| $1.04M | 0.04% |
25,824
+5,622
| +28% | +$226K |
|
295
Colgate-Palmolive
CL
$68.1B
| $1.03M | 0.04% |
11,299
-2,105
| -16% | -$191K |
|
296
Arthur J. Gallagher & Co
AJG
$76.5B
| $1.02M | 0.04% |
3,199
-350
| -10% | -$112K |
|
297
Equinix
EQIX
$76.3B
| $1.02M | 0.04% |
1,287
-13
| -1% | -$10.3K |
|
298
AB InBev
BUD
$116B
| $1.02M | 0.04% |
14,844
+514
| +4% | +$35.3K |
|
299
PTC Therapeutics
PTCT
$4.64B
| $1.02M | 0.04% |
20,842
+8,131
| +64% | +$397K |
|
300
Apollo Global Management
APO
$76.9B
| $1.02M | 0.04% |
7,168
-100
| -1% | -$14.2K |
|